🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Junko Tsuji

Broad Institute

ORCID: 0000-0003-0139-3750
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.613Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3251
Top 32%
0.613DataRank
Top 32%15 citations

Jingxin Fu, Carrie Cibulskis, Aashna Jhaveri, Curtis Gumbs, Biswajit Das +41 more

Papers

Driven by 12 papers — median percentile 68. Top paper: “Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial”.

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00658-6
N/A
4.8DataRank · unranked
234 citations

Anita Giobbie‐Hurder, Srinika Ranasinghe, Katrina Kao, Ana Lako, Junko Tsuji +32 more

Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2305
N/A
0.918DataRank · unranked
28 citations

Tianyu Li, Albert Grinshpun, Tim H. H. Coorens, Douglas Russo, Leilani Anderson +16 more

Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3251
Top 32%
0.613DataRank
Top 32%15 citations

Jingxin Fu, Carrie Cibulskis, Aashna Jhaveri, Curtis Gumbs, Biswajit Das +41 more

Donor clonal hematopoiesis and recipient outcomes after transplantation

medRxiv(2021)10.1101/2021.09.25.21263697
N/A
0.425DataRank · unranked
16 citations

Haesook T. Kim, Lin Zhao, H. Moses Murdock, Bryan C. Hambley, Alana F. Ogata +24 more

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone

medRxiv(2024)10.1101/2024.04.19.24306082
N/A
0.343DataRank · unranked
6 citations

Michelle P. Aranha, Robert Redd, Michael Timonian, Sophie Magidson, Elizabeth D. Lightbody +17 more

Somatic piRNAs and Transposons are Differentially Expressed Coincident with Skeletal Muscle Atrophy and Programmed Cell Death

Frontiers in Genetics(2021)10.3389/fgene.2021.775369
N/A
0DataRank · unranked
12 citations

Travis Thomson, Christine Brown, Subhanita Ghosh, William E. Theurkauf, Zhiping Weng +2 more

Integrated miRNA-/mRNA-Seq of the Habenulo-Interpeduncular Circuit During Acute Nicotine Withdrawal

Scientific Reports(2020)10.1038/s41598-020-57907-w
N/A
0DataRank · unranked
12 citations

Junko Tsuji, Rubing Zhao-Shea, Ciearra B. Smith, Susanna Molas, Andrew R. Tapper +3 more

Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.01.551480
N/A
0DataRank · unranked
2 citations

Elizabeth D. Lightbody, Mairéad Reidy, Junko Tsuji, Michelle P. Aranha, Daniel Heilpern-Mallory +15 more

Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial

Nature Communications(2025)10.1038/s41467-024-55308-5
N/A
0DataRank · unranked
14 citations

Michelle P. Aranha, Robert Redd, Michael Timonian, Sophie Magidson, Elizabeth D. Lightbody +17 more

Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom’s Macroglobulinemia

Nature Communications(2025)10.1038/s41467-025-56323-w
N/A
0DataRank · unranked
13 citations

Yoshinobu Konishi, Daniel Heilpern-Mallory, Ting Wu, Nicholas Tsakmaklis, Michelle P. Aranha +17 more

Numbat-multiome: inferring copy number variations by combining RNA and chromatin accessibility information from single-cell data

Briefings in Bioinformatics(2025)10.1093/bib/bbaf516
N/A
0DataRank · unranked
3 citations

Jean-Baptiste Alberge, Tina Keshavarzian, Junko Tsuji, Johan E. Gustafsson, Mahshid Rahmat +13 more

Somatic piRNAs and Transposons are Differentially Regulated During Skeletal Muscle Atrophy and Programmed Cell Death

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.02.433533
N/A
0DataRank · unranked
0 citations

Travis Thomson, Christine Brown, Subhanita Ghosh, William E. Theurkauf, Zhiping Weng +2 more